SCHEMBL6561465

SCHEMBL6561465

Cc1c[nH]c(=O)n1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL221825 0.75 SLC9A1 (0.41)
SCHEMBL20014008 0.72
SCHEMBL16652006 0.69 ADORA2A (0.36)
SCHEMBL2078821 0.69 ADORA2A (0.36)
SCHEMBL11480635 0.69 ADORA2A (0.36)
SCHEMBL25979874 0.69 ADORA2A (0.36)
SCHEMBL9770361 0.68
SCHEMBL19243050 0.67 NOTUM (0.40)
SCHEMBL19586641 0.67
SCHEMBL13469216 0.67 ADORA2A (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021163727-A1 PIKFYVE KINASE INHIBITORS AcuraStem Incorporated (US) 2021-08-19 WO disclosed
WO-2021032209-A1 ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF 四川海思科制药有限公司 2021-02-25 WO disclosed
EP-3092227-B1 BICYCLIC HETEROCYCLIC DERIVATIVES AS BROMODOMAIN INHIBITORS ORION CORP (FI) 2018-07-11 EP disclosed
US-20170143708-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF AGELASTATIN ALKALOIDS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2017-05-25 US disclosed
US-9527828-B2 Method for expanding hematopoietic stem cells using heterocyclic compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-12-27 US disclosed
US-9527828-B2 Method for expanding hematopoietic stem cells using heterocyclic compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-12-27 US disclosed
US-20160368906-A1 BICYCLIC HETEROCYCLIC DERIVATIVES AS BROMODOMAIN INHIBITORS ORION CORPORATION (FI) 2016-12-22 US disclosed
EP-2218716-B1 METHOD FOR AMPLIFYING HEMATOPOIETIC STEM CELLS USING HETEROCYCLIC COMPOUND NISSAN CHEMICAL IND LTD (JP) 2016-11-16 EP disclosed
US-9328085-B2 Heterocyclic compounds and expansion agents for hematopoietic stem cells NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-05-03 US disclosed
US-9328085-B2 Heterocyclic compounds and expansion agents for hematopoietic stem cells NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-05-03 US disclosed
US-20080312270-A1 COMPOUNDS AND METHODS USEFUL FOR TREATING ASTHMA AND ALLERGIC INFLAMMATION AMGEN INC. 2008-12-18 US disclosed
WO-2008137027-A2 COMPOUNDS AS CRTH2 AND/OR PGD2 RECEPTORS MODULATORS AND THEIR USE FOR TREATING ASTHMA AND ALLERGIC INFLAMMATION AMGEN INC. (US) 2008-11-13 WO disclosed
US-20070161681-A1 ETHER DERIVATIVES USEFUL AS INHIBITORS OF PDE4 ISOZYMES PFIZER INC. (US) 2007-07-12 US disclosed
US-7183293-B2 Ether derivatives useful as inhibitors of PDE4 isozymes PFIZER INC. (US) 2007-02-27 US disclosed
EP-0978546-B1 Ink compositions containing an ammonium carboxylate salt HEWLETT PACKARD CO (US) 2004-03-24 EP disclosed
EP-0978546-A1 Ink compositions containing an ammonium carboxylate salt Hewlett-Packard Company (US) 2000-02-09 EP disclosed
US-5925176-A INK COMPRISING AMMONIUM CARBOXYLATE SALT AND SURFACTANT; PREVENTS THERMALLY INDUCED PHASE SEPARATION HEWLETT-PACKARD COMPANY (US) 1999-07-20 US disclosed
EP-0544487-B1 Anti-coalescent ink composition and method for making the same HEWLETT PACKARD CO (US) 1996-07-03 EP disclosed
EP-0544487-A1 Anti-coalescent ink composition and method for making the same Hewlett-Packard Company (US) 1993-06-02 EP disclosed
US-5188664-A Combining chemical dye with polyether polyol to reduce surface tension and to increase drip mass per firing HEWLETT-PACKARD COMPANY (US) 1993-02-23 US disclosed